[Osteoporosis management in general practice. Preventing spontaneous bone fractures].
D050071:Bone Density Conservation Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D012968:Etidronic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005598:Fractures, Spontaneous / Q000517:prevention & control*; D006801:Humans; D000068296:Risedronic Acid; D016103:Spinal Fractures / Q000517:prevention & control*; D014807:Vitamin D / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D014807:Vitamin D; D000068296:Risedronic Acid; D012968:Etidronic Acid; D002118:Calcium